BSE filing, NSE: SOUTLAT. Summary written from the filing by ALFA Finder's alert engine.
Southern Latex Ltd: key numbers
- Share price
- ₹26.72
- Market cap
- ₹19.66 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.28 Cr
- P/E (TTM)
- 68.5×Sector 49.0×
- Promoter holding
- 65.57%+0.00% QoQ
- FII holding
- 1.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Southern Latex Ltd
All →Southern Latex Other Announcement
Southern Latex Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance filing.
Southern Latex Annual General Meeting
Southern Latex Ltd held its Annual General Meeting on September 10, 2026. Shareholders approved resolutions regarding the company's name change and amendments to its object clause.
Southern Latex Other Announcement
Southern Latex dispatched letters to shareholders with unregistered emails, providing a weblink to access the company's FY 2025-26 Annual Report and AGM Notice.
Southern Latex Annual General Meeting
Southern Latex Ltd issued a corrigendum to its 37th AGM Notice, including a Chartered Accountant's certificate required for the proposed change of the company's name.
Southern Latex Annual Report
Southern Latex Limited has filed its Annual Report for the financial year 2025-26, in compliance with Regulation 34(1) of the SEBI LODR Regulations.
Southern Latex Annual General Meeting
Southern Latex Limited has issued the notice for its 37th Annual General Meeting scheduled for 10th September 2026. The meeting will be conducted via video conferencing.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.